Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Status:
Recruiting

Trial end date:
2028-12-01

Target enrollment:

Participant gender:

This study is an open-label, international, multi-center, Phase 1 study in adult patients with solid tumors likely to express CLDN18.2.

Phase 1

Elevation Oncology